Early research (Phase 1)Study completedNCT00017264
What this trial is testing
Atrasentan in Treating Patients With Progressive or Recurrent Malignant Glioma
Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)